SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001835268-24-000019
Filing Date
2024-08-02
Accepted
2024-08-02 17:13:51
Documents
1
Period of Report
2024-08-02

Document Format Files

Seq Description Document Type Size
1 6-K connectform6-kaugust2024xw.htm 6-K 20045
  Complete submission text file 0001835268-24-000019.txt   21098
Mailing Address 12265 EL CAMINO REAL, SUITE 350 SAN DIEGO CA 92130
Business Address 12265 EL CAMINO REAL, SUITE 350 SAN DIEGO CA 92130 858-727-1040
Connect Biopharma Holdings Ltd (Filer) CIK: 0001835268 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40212 | Film No.: 241172152
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)